PHARMACOKINETICS OF INTRAVENOUS, INTRAPERITONEAL, AND SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CAPD - A RATIONALE FOR TREATMENT

被引：0
|
作者：
MACDOUGALL, IC
ROBERTS, DE
NEUBERT, P
DHARMASENA, AD
COLES, GA
WILLIAMS, JD
机构：
来源：
ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION | 1989年 / 76卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：112 / 121
页数：10
相关论文
共 50 条
  • [21] PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE INTRAVENOUS AND SUBCUTANEOUS DOSES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEALTHY-MEN
    FLAHARTY, KK
    CARO, J
    BJORNSSON, TD
    VLASSES, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 178 - 178
  • [22] Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients
    Elwell, RJ
    Manley, HJ
    Frye, RF
    Bailie, GR
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (08): : 808 - 816
  • [23] EFFECTS OF LONG-TERM TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CAPD
    STEINHAUER, HB
    NEW PERSPECTIVES IN HEMODIALYSIS, PERITONEAL DIALYSIS, ARTERIOVENOUS HEMOFILTRATION, AND PLASMAPHERESIS, 1989, 260 : 157 - 165
  • [24] COMPARATIVE-STUDY OF INTRAPERITONEAL AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO) IN PATIENTS TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    COPPENS, PJW
    FRENKEN, LAM
    STRUIJK, DG
    TIGGELER, RGWL
    KREDIET, RT
    KOENE, RAP
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 326 - 326
  • [25] PHARMACOKINETICS AND DOSE-RESPONSE AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON REGULAR HEMODIALYSIS-TREATMENT OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    STOCKENHUBER, F
    LOIBL, U
    GOTTSAUNERWOLF, M
    JAHN, C
    MANKER, W
    MEISL, TF
    BALCKE, P
    NEPHRON, 1991, 59 (03) : 399 - 402
  • [26] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BARNAS, U
    WATZINGER, U
    PEER, G
    MAYER, G
    GRAF, H
    NEFROLOGIA, 1990, 10 : 116 - 120
  • [27] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [28] The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin
    Xenocostas, A
    Cheung, W
    Zakszewski, C
    Kelly, M
    Lutynski, A
    Crump, M
    Lipton, J
    Kiss, T
    Messner, H
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 42 - 42
  • [29] The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin
    Anargyros Xenocostas
    Wing K. Cheung
    Francis Farrell
    Cindy Zakszewski
    Marian Kelley
    Andrzej Lutynski
    Michael Crump
    Jeffrey H. Lipton
    Thomas L. Kiss
    Catherine Y. Lau
    Hans A. Messner
    European Journal of Clinical Pharmacology, 2005, 61 : 189 - 195
  • [30] The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin
    Xenocostas, A
    Cheung, WK
    Farrell, F
    Zakszewski, C
    Kelley, M
    Lutynski, A
    Crump, M
    Lipton, JH
    Kiss, TL
    Lau, CY
    Messner, HA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (03) : 189 - 195
12345